Chronic marijuana usage by human pancreas donors is associated with impaired islet function
暂无分享,去创建一个
J. Rawson | F. Kandeel | M. Qi | B. Roep | J. Isenberg | Z. Chen | J. Kaddis | S. Dhawan | I. Al-Abdullah | K. Omori | Kuan-Tsen Chen | Jeffrey Rawson
[1] J. Egan,et al. An Autonomous Cannabinoid System in Islets of Langerhans , 2021, Frontiers in Endocrinology.
[2] Lucas T. Laudermilk,et al. Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in Mice. , 2021, ACS pharmacology & translational science.
[3] C. Meisinger,et al. Cannabis use does not impact on type 2 diabetes: A two‐sample Mendelian randomization study , 2021, Addiction biology.
[4] J. Petrik,et al. Gestational exposure to Δ9-THC impacts ovarian follicular dynamics and angiogenesis in adulthood in Wistar rats , 2021, Journal of Developmental Origins of Health and Disease.
[5] N. Rogers,et al. CD47 Promotes Age-Associated Deterioration in Angiogenesis, Blood Flow and Glucose Homeostasis , 2020, Cells.
[6] J. Rawson,et al. Semi-Automated Assessment of Human Islet Viability Predicts Transplantation Outcomes in a Diabetic Mouse Model , 2020, Cell transplantation.
[7] S. Romero-Zerbo,et al. The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease , 2020, Frontiers in Endocrinology.
[8] B. Lutz,et al. Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult neurogenesis , 2019, Psychoneuroendocrinology.
[9] G. Kinney,et al. Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry , 2019, Diabetes Care.
[10] W. Levack,et al. Using cannabis for pain management after spinal cord injury: a qualitative study. , 2019, Spinal cord series and cases.
[11] N. Skakkebaek,et al. Characterisation and localisation of the endocannabinoid system components in the adult human testis , 2019, Scientific Reports.
[12] H. François,et al. The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept , 2019, Journal of cellular and molecular medicine.
[13] F. Pattou,et al. Islets for Research: Nothing Is Perfect, but We Can Do Better , 2019, Diabetes.
[14] J. Yee,et al. Pancreatic human islets and insulin-producing cells derived from embryonic stem cells are rapidly identified by a newly developed Dithizone , 2019, Scientific Reports.
[15] M. Olfson,et al. Use of marijuana exclusively for medical purposes. , 2019, Drug and alcohol dependence.
[16] G. Kinney,et al. Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes , 2019, JAMA internal medicine.
[17] A. Powers,et al. Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions , 2018, Diabetologia.
[18] A. Csoka,et al. Epigenetic Effects of Drugs of Abuse , 2018, International journal of environmental research and public health.
[19] J. Egan,et al. Endocannabinoids in the Islets of Langerhans: the ugly, the bad, and the good facts. , 2018, American journal of physiology. Endocrinology and metabolism.
[20] K. Becker,et al. Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets , 2018, Diabetologia.
[21] R. Kulkarni,et al. Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells , 2018, Journal of cellular and molecular medicine.
[22] J. Roberts,et al. History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist , 2018, Transplantation.
[23] Y. Tai,et al. Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival , 2017, PloS one.
[24] W. Baumgärtner,et al. Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system , 2017, PloS one.
[25] M. Atkinson,et al. High Illicit Drug Abuse and Suicide in Organ Donors With Type 1 Diabetes , 2017, Diabetes Care.
[26] Shikha Prashad,et al. Cognitive motor deficits in cannabis users , 2017, Current Opinion in Behavioral Sciences.
[27] A. Howlett,et al. CB1 and CB2 Receptor Pharmacology. , 2017, Advances in pharmacology.
[28] P. Allebeck,et al. Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women , 2016, Journal of diabetes research.
[29] Qing-Rong Liu,et al. Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism , 2016, Scientific Reports.
[30] G. Szot,et al. National Institutes of Health–Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities , 2016, Diabetes.
[31] James D. Johnson,et al. Reduced Insulin Production Relieves Endoplasmic Reticulum Stress and Induces β Cell Proliferation. , 2016, Cell metabolism.
[32] Sue Pondrom. Transplantation and Marijuana Use , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[33] J. Rawson,et al. Human Pancreatic Islets Isolated from Donors with Elevated HbA1c Levels: Islet Yield and Graft Efficacy , 2015, Cell Transplantation.
[34] M. Atkinson,et al. A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository? , 2015, Current opinion in endocrinology, diabetes, and obesity.
[35] Kuei Yuan Tseng,et al. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex , 2014, Molecular Psychiatry.
[36] N. Volkow,et al. Metabolic Effects of Chronic Cannabis Smoking , 2013, Diabetes Care.
[37] A. Albini,et al. Cannabidiol inhibits angiogenesis by multiple mechanisms , 2012, British journal of pharmacology.
[38] M. Atkinson,et al. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes , 2012, Diabetes/metabolism research and reviews.
[39] M. Gorospe,et al. Cannabinoids Induce Pancreatic β-Cell Death by Directly Inhibiting Insulin Receptor Activation , 2012, Science Signaling.
[40] Gao Huang,et al. Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans , 2011, Diabetes, obesity & metabolism.
[41] M. Doyle,et al. Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function , 2011, Islets.
[42] Yan Wang,et al. Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells , 2011, Diabetes.
[43] Chen Li,et al. Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. , 2011, Pharmacology & therapeutics.
[44] P. Austin,et al. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies , 2010, Pharmaceutical statistics.
[45] Yan Wang,et al. Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells , 2011, Diabetes.
[46] Joyce C Niland,et al. Human pancreatic islets and diabetes research. , 2009, JAMA.
[47] R. Pratley,et al. The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. , 2008, Biochemical and biophysical research communications.
[48] M. Nakata,et al. Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors , 2008, Regulatory Peptides.
[49] F. Bermúdez-Silva,et al. Presence of functional cannabinoid receptors in human endocrine pancreas , 2008, Diabetologia.
[50] F. Pentimalli,et al. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). , 2007, Oncology reports.
[51] Wolfgang Moritz,et al. Superiority of Small Islets in Human Islet Transplantation , 2007, Diabetes.
[52] M. Pletcher,et al. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). , 2006, The American journal of cardiology.
[53] M. Elsohly,et al. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. , 2005, Life sciences.
[54] K. Mackie,et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. , 2005, The Journal of clinical investigation.
[55] N. Zhang,et al. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. , 2004, Diabetes.
[56] H. Bank. Assessment of islet cell viability using fluorescent dyes , 1987, Diabetologia.
[57] C. Crespo,et al. Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey , 2001, Public Health Nutrition.
[58] R. D'Agostino. Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .
[59] Camillo Ricordi,et al. Automated Method for Isolation of Human Pancreatic Islets , 1988, Diabetes.